Expertise in
1
conditions

Henning W. Zimmermann

St. Antonius Krankenhaus
Eschweiler Ueber Feld, NW, DE 
Expertise in
1
conditions
St. Antonius Krankenhaus
Eschweiler Ueber Feld, NW, DE 

Overview

Henning Zimmermann practices practicing medicine in Eschweiler Ueber Feld, Germany.

Mr. Zimmermann is highly rated in 1 condition, according to our data. His clinical expertise encompasses Cirrhosis, Spontaneous Bacterial Peritonitis, Ascites, and Secondary Peritonitis.

He is actively involved in clinical research, co-authoring 42 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

St. Antonius Krankenhaus
Eschweiler Ueber Feld, NW, Germany
Other Locations
Aachen, NW, Germany
Jena, TH 07740, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 2, Single-blinded, Randomised, Controlled Multi-country Study to Evaluate the Safety, Reactogenicity, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide (ASO) Against Chronic Hepatitis B (CHB) Followed by Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy
A Phase 2, Single-blinded, Randomised, Controlled Multi-country Study to Evaluate the Safety, Reactogenicity, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide (ASO) Against Chronic Hepatitis B (CHB) Followed by Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy
Enrollment Status: Completed
Publish Date: December 30, 2025
Intervention Type: Drug, Biological
Study Drugs: GSK3228836, GSK3528869A
Study Phase: Phase 2

42 Total Publications

Serial percutaneous endoscopic necrosectomy (SPEN) after initial VARD for necrotizing pancreatitis: a retrospective single-center observational study.
Serial percutaneous endoscopic necrosectomy (SPEN) after initial VARD for necrotizing pancreatitis: a retrospective single-center observational study.
Journal: Surgical endoscopy
Published: August 08, 2025

Frequently Asked Questions about Henning W. Zimmermann

Is Henning W. Zimmermann a top-rated expert for Cirrhosis?

MediFind is an objective health platform that identifies experts based on real-world data. Henning W. Zimmermann is classified as an Advanced expert for Cirrhosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Henning W. Zimmermann participate in research or clinical trials?

Yes. Henning W. Zimmermann has published 42 articles and abstracts on conditions like Cirrhosis. You can view a list of Henning W. Zimmermann's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Zimmermann's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile